In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer
Authors:
- Emmanuelle N. SabbahESEmmanuelle N. Sabbah
- Jean KadoucheJKJean Kadouche
- David EllisonDEDavid Ellison
- Ciara FinucaneCFCiara Finucane
- Didier DecaudinDDDidier Decaudin
- Stephen J. MatherSMStephen J. Mather
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 34 (3) , 293-304
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adjuvant Treatment Strategies for Pancreatic CancerJournal of Gastrointestinal Surgery, 2006
- Current therapies and advances in the treatment of pancreatic cancerCritical Reviews in Oncology/Hematology, 2006
- Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted TherapyClinical Cancer Research, 2006
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Monoclonal Antibody 16D10 to the C-Terminal Domain of the Feto-Acinar Pancreatic Protein Binds to Membrane of Human Pancreatic Tumoral SOJ-6 Cells and Inhibits the Growth of Tumor XenograftsNeoplasia, 2004
- Improved Targeting of Pancreatic CancerClinical Cancer Research, 2004
- Combined 90Yttrium‐DOTA‐labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograftInternational Journal of Cancer, 2004
- Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinomaJournal of Surgical Oncology, 2003
- Efficacy of Monoclonal Antibody 131I-B72.3 Immunoscintigraphy of Pancreatic Adenocarcinoma Xenografts in Nude MiceThe European Journal of Surgery, 1999
- Radioimmunoimaging of Xenograft Pancreatic Cancer with 131I-Monoclonal Antibody P2Pancreas, 1993